News & Updates

Accelerometry appears to be an accurate measure of quality of life (QoL) in patients with malignant pleural effusion (MPE), as shown in a study. It is also a useful tool for examining subtle differences in patients following various treatment regimens, particularly drainage protocols in MPE.

The monoclonal antibody dupilumab, alone or in combination with conventional agents, appeared to effectively control bullous pemphigoid (BP), a study from China has shown.

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Individuals who use proton pump inhibitors (PPIs) appear to be at heightened risk of pneumonia, as reported in a study.

For older people, administering metformin before or during a period of reduced physical activity appears to have potential benefits for the muscles, such as reducing atrophy and improving recovery, as reported by a team of US-based researchers.

In South Korea, the rate of suicide is particularly increased among individuals diagnosed with sight-threatening eye disease (STED) between 2010 and 2020, reveals a study.